MAESTrO: Blog

Posted by Michael Wonder on 14 Oct 2016

TGA publishes AusPAR for Entresto

14 October 2016 - The TGA has published an AusPAR for Novartis' Entresto. ...

Posted by Michael Wonder on 13 Oct 2016

FY 2016 generic approvals by FDA: a new record under GDUFA

12 October 2016 - The US FDA published final Fiscal Year 2016 abbreviated new drug application (ANDA) approvals earlier this ...

Read more →

Posted by Michael Wonder on 12 Oct 2016

EMA publishes EPAR for Cabometyx (cabozantinib maleate)

12 October 2016 - The EMA has published an EPAR for Ipsen's Cabometyx. ...

Read more →

Posted by Michael Wonder on 11 Oct 2016

ICER releases corrected evidence report on treatments for non-small-cell lung cancer

7 October 2016 - PD-1 value-based price benchmarks are updated while the main conclusions of the analysis remain unchanged. ...

Read more →

Posted by Michael Wonder on 09 Oct 2016

Human medicines highlights - September 2016

7 October 2016 - Key information for patients, consumers and healthcare professionals published monthly by the EMA. ...

Read more →

Posted by Michael Wonder on 30 Sep 2016

EMA publishes EPAR for Truberzi

29 September - The EMA has published an EPAR for Allergan's Truberzi (eluxadoline). ...

Read more →

Posted by Michael Wonder on 29 Sep 2016

ICER releases evidence report on treatments for non-small cell lung cancer

29 September 2016 - The Institute for Clinical and Economic Review has released an evidence report assessing the comparative clinical effectiveness ...

Read more →

Posted by Michael Wonder on 29 Sep 2016

EMA publishes EPAR for Nordimet

29 September 2016 - The EMA has published an EPAR for Nordic Pharma's Nordimet. ...

Read more →

Posted by Michael Wonder on 28 Sep 2016

TGA performance statistics report: July 2015 to June 2016

28 September 2016 - The TGA, through the Performance Statistics Report, provides detailed statistical information on its performance to stakeholders. ...

Read more →